100 Cyberonics Boulevard
United States - Map
Cyberonics, Inc., together with its subsidiaries, engages in the design, development, marketing, and sale of implantable medical devices to hospitals and ambulatory surgery centers. The company offers vagus nerve stimulation (VNS) therapy system that provides neuromodulation therapy for the treatment of refractory epilepsy and treatment-resistant depression. It also engages in investigating the use of VNS and other neuromodulation therapy for other indications, including chronic heart failure, and developing non-implantable device solutions for the management of epilepsy. The company sells its products directly, as well as through independent distributors in Europe, Canada, Mexico, Australia, parts of Central and South America, the Middle East, China, Japan, and other parts of Asia. Cyberonics, Inc. was founded in 1987 and is headquartered in Houston, Texas.
|Cyberonics Inc.’s ISS Governance QuickScore as of Nov 1, 2013 is 2. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 5; Compensation: 2.|
|Brought to you by Institutional Shareholder Services (ISS)|
|Mr. Daniel Jeffrey Moore ,
Chief Exec. Officer, Pres and Exec. Director
|Mr. Gregory H. Browne ,
Chief Financial Officer, Principal Accounting Officer and Sr. VP of Fin.
|Mr. David S. Wise ,
Chief Admin. Officer, Sr. VP and Sec.
|Dr. Milton M. Morris Ph.D.,
Sr. VP of R&D
|Dr. Bruce H. KenKnight Ph.D.,
VP of Emerging Therapies
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|